Business Decibel Cannabis secures $54M in debt refinancing The firm expects the proceeds and funds from operations to be enough to repay its convertible debentures on maturity Nick LabaJanuary 14, 2022
Business Numinus submits novel psilocybe formulation for clinical trial If approved, it will mark the firm's first independent clinical trial with a proprietary extract Nick LabaJanuary 14, 2022
Driving THC-related driving injuries doubled since legalization: UBC study The largest increase in drivers with moderate injuries was seen in men over 50 Natalia Buendia CalvilloJanuary 14, 2022
Business Flowr Corp ships $825K of pot to Israel The firm is also expecting a first harvest at its Portugal facility this month Nick LabaJanuary 13, 2022
International Italian court certifies signatures to trigger cannabis referendum The Constitutional Court still needs to issue an opinion and set a date for the vote, which advocates hope could come as early as... Kathryn TindaleJanuary 13, 2022
Business Victoria trims cannabis retail fees City council voted Thursday to reduce the licensing fee to $3,500 in 2022 from $5,000 previously Nick LabaJanuary 13, 2022
Business Kelowna and Vernon to slash pot shop fees Business licensing fees for cannabis stores are higher than any other category Nick LabaJanuary 12, 2022
Business Leafly to raise US$30M in convertible notes ahead of public listing The new financing deal will delay a vote by Merida shareholders to approve its merger deal with Leafly Nick LabaJanuary 12, 2022
Hemp Portugal defines new rules for industrial hemp cultivation The amendment is meant to address insufficient regulations Kathryn TindaleJanuary 11, 2022
Canada ATMA to run clinical trial for synthetic psilocybin on medical professionals Following the trial's approval from Health Canada, psychedelic practitioners can now apply to be research subjects Natalia Buendia CalvilloJanuary 11, 2022